A solution to obtain structural information quickly for effective quality control of pharmaceuticals during production or to study ageing effects and other properties.
This article provides a list of state-level resources which include specific guidance on combustible dust when available, as well as links to state OSHA offices, labor departments and safety programs.
While QbD evolves from good practice to agency requirement, how can sponsors ensure that rigorous, scientific risk-based approaches are used to bring better and safer therapies to market faster?
By recognizing the limitations of today’s production processes, the industry may be able to overcome the challenges, complexity, and high cost of manufacturing vaccines and viral vector-based therapies.
Selecting a partner is challenging, but with the right information you can simplify your efforts and increase your likelihood of making the best decision.
Identifying the source of product flow problems and correcting them with the right piece of equipment will result in more efficient and quality manufacturing.
How factors such as R&D vs. production press as well as compaction dwell time can affect your scale-up.
Materials science is now helping pharmaceutical companies to standardize and control areas such as drug form and manufacture to deliver new products more quickly and with greater quality.
Tips to prevent bioburden entry and proliferation, and reduce the complexity of the equipment and processes involved.
Through a successful implementation, Fujifilm was able to not only recognize the benefits an integrated automation platform offers but also the importance of working with an experienced partner.
|
|
|
|
|
|
|
|
|